Literature DB >> 9154025

Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series.

J A Summerfield1, M Sumiya, M Levin, M W Turner.   

Abstract

OBJECTIVE: To determine the extent to which mutations in the mannose binding protein gene predispose to childhood infection.
DESIGN: Clinical details and genotype of mannose binding protein determined in consecutive children attending a paediatric department.
SETTING: Inner city hospital paediatric service in London.
SUBJECTS: 617 children attending hospital between October 1993 and August 1995. MAIN OUTCOME MEASURE: Infection as the cause for attendance or admission in relation to mutations in the mannose binding protein gene.
RESULTS: The prevalence of mutations in the mannose binding protein gene in children with infection (146/345) was about twice that in children without infection (64/272) (P < 0.0001). Increased susceptibility to infection was found in both heterozygotic and homozygotic children. 13 out of 17 children homozygotic for variant alleles presented with strikingly severe infections, including 6 with septicaemia.
CONCLUSIONS: The findings suggest that mutations in the mannose binding protein gene are an important risk factor for infections in children. Screening for such mutations should be included in the investigation of severe or frequent infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154025      PMCID: PMC2126595          DOI: 10.1136/bmj.314.7089.1229

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  80 in total

1.  Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes.

Authors:  N Baxter; M Sumiya; S Cheng; H Erlich; L Regan; A Simons; J A Summerfield
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis.

Authors:  M Gabolde; D Hubert; M Guilloud-Bataille; C Lenaerts; J Feingold; C Besmond
Journal:  J Med Genet       Date:  2001-05       Impact factor: 6.318

Review 3.  Neutrophil disorders and their management.

Authors:  R Lakshman; A Finn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 4.  The immunopathogenesis of meningococcal disease.

Authors:  A J Kvalsvig; D J Unsworth
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

Review 5.  Complement genetics, deficiencies, and disease associations.

Authors:  Karine R Mayilyan
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

6.  Anti-endothelial cell antibodies in rheumatic heart disease.

Authors:  V Scalzi; H Abu Hadi; C Alessandri; C Croia; V Conti; L Agati; A Angelici; V Riccieri; C Meschini; A Al-Motarreb; A Al-Ansi; G Valesini
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

7.  Glycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-binding lectin.

Authors:  Kenji Kurokawa; Dong-Jun Jung; Jang-Hyun An; Katharina Fuchs; Yu-Jin Jeon; Na-Hyang Kim; Xuehua Li; Koichiro Tateishi; Ji Ae Park; Guoqing Xia; Misao Matsushita; Kazue Takahashi; Hee-Ju Park; Andreas Peschel; Bok Luel Lee
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

8.  Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system.

Authors:  M Cedzynski; J Szemraj; A S Swierzko; L Bak-Romaniszyn; M Banasik; K Zeman; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 9.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

10.  Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice.

Authors:  J Østergaard; S Thiel; M Gadjeva; T K Hansen; R Rasch; A Flyvbjerg
Journal:  Diabetologia       Date:  2007-05-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.